Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16084847 | 0.88 | MEN1 (0.46) | MEN1CYP3A4ALOX15KMT2A | |
| SCHEMBL125579 | 0.80 | MEN1 (0.36) | MEN1CYP3A4ALOX15KMT2AL3MBTL1 | |
| SCHEMBL29281171 | 0.76 | MEN1 (0.34) | MEN1CYP3A4ALOX15KMT2AL3MBTL1 | |
| SCHEMBL487775 | 0.76 | MEN1 (0.34) | MEN1CYP3A4ALOX15KMT2AL3MBTL1 | |
| SCHEMBL5697169 | 0.75 | — | — | |
| SCHEMBL13126739 | 0.75 | MEN1 (0.32) | MEN1CYP3A4ALOX15KMT2ACYP1A2 | |
| SCHEMBL6052829 | 0.75 | — | — | |
| SCHEMBL1698190 | 0.75 | MEN1 (0.32) | MEN1CYP3A4ALOX15KMT2ACYP1A2 | |
| SCHEMBL28044226 | 0.74 | MEN1 (0.33) | MEN1CYP3A4ALOX15KMT2A | |
| SCHEMBL28654262 | 0.74 | MEN1 (0.33) | MEN1CYP3A4ALOX15KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119192025-A | Industrial preparation method and application of alpha-hydroxynitrile | 哈尔滨理工大学 | 2024-12-27 | — | — | CN | disclosed |
| EP-1160235-B1 | A method for producing alpha-hydroxycarboxylic acid | NIPPON CATALYTIC CHEM IND (JP) | 2006-09-20 | — | — | EP | disclosed |
| US-6864389-B2 | Method for producing α-hydroxycarboxylic acid | NIPPON SHOKUBAI CO., LTD. (JP) | 2005-03-08 | — | — | US | disclosed |
| US-20030171614-A1 | Method for producing alpha-hydroxycarboxylic acid | NIPPON SHOKUBAI CO., LTD. | 2003-09-11 | — | — | US | disclosed |
| EP-1160235-A2 | A method for producing alpha-hydroxycarboxylic acid | Nippon Shokubai Co., Ltd. (JP) | 2001-12-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030171614-A1 | Method for producing alpha-hydroxycarboxylic acid | HAAO, HCAR1, HAO2 | MEN1 2723/4885CYP3A4 193/4885ALOX15 17/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.